Polyrizon Ltd. Revenue and Competitors

We are a development stage biotech company specializing in the development of innovative medical device hydrogels delivered in the form\nof nasal sprays, which form a thin hydrogel-based shield containment barrier in the nasal cavity that can provide a barrier against viruses\nand allergens from contacting the nasal epithelial tissue. Our proprietary Capture and Contain TM, or C&C, hydrogel technology, comprised\nof a mixture of naturally occurring building blocks, is delivered in the form of nasal sprays, and potentially functions as a “biological mask”\nwith a thin shield containment barrier in the nasal cavity. We are further developing certain aspects of our C&C hydrogel technology such\nas the bioadhesion and prolonged retention at the nasal deposition site for intranasal delivery of drugs. We refer to our additional\ntechnology, which is in an earlier stage of pre-clinical development, that is focused on nasal delivery of active pharmaceutical ingredients, or\nAPIs, as Trap and Target ™, or T&T.